Genetic variations and haplotype diversity of the ugt1 gene cluster in the chinese population

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Yang, Jing ^a,b   Cai, Lei ^a,b   Huang, Haiyan ^a,b   Liu, Bingya ^a   Wu, Qiang ^a,b  

^a Chinese National Human Genome Center at Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A5; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A9; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CHINESE; EXON; GENE; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; INTRON; MOLECULAR GENETICS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UGT1 GENE; ASIAN; GENETICS; MULTIGENE FAMILY;

VERTEBRATA;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859703454     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033988     Document Type: Article

References (53)

1. Zipursky SL, Sanes JR, (2010) Chemoaffinity revisited: Dscams, protocadherins, and neural circuit assembly. Cell 143: 343-353.
2. Muotri AR, Gage FH, (2006) Generation of neuronal variability and complexity. Nature 441: 1087-1093.
3. Evans WE, Relling MV, (1999) Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286: 487-491.
4. Litman GW, Dishaw LJ, Cannon JP, Haire RN, Rast JP, (2007) Alternative mechanisms of immune receptor diversity. Curr Opin Immunol 19: 526-534.
5. Noonan JP, Li J, Nguyen L, Caoile C, Dickson M, et al. (2003) Extensive linkage disequilibrium, a common 16.7-kilobase deletion, and evidence of balancing selection in the human protocadherin alpha cluster. Am J Hum Genet 72: 621-635.
6. Noonan JP, Grimwood J, Schmutz J, Dickson M, Myers RM, (2004) Gene conversion and the evolution of protocadherin gene cluster diversity. Genome Res 14: 354-366.
7. Li C, Wu Q, (2007) Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes. BMC Evol Biol 7: 69.
8. Ménard V, Eap O, Harvey M, Guillemette C, Lévesque É, (2009) Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Hum Mutat 30: 1310-1319.
9. Ménard V, Girard H, Harvey M, Pérusse L, Guillemette C, (2009) Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat 30: 677-687.
10. Wu Q, Maniatis T, (1999) A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97: 779-790.
11. Zhang T, Haws P, Wu Q, (2004) Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res 14: 79-89.
12. Tasic B, Nabholz CE, Baldwin KK, Kim Y, Rueckert EH, et al. (2002) Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing. Mol Cell 10: 21-33.
13. Wang X, Su H, Bradley A, (2002) Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model. Genes Dev 16: 1890-1905.
14. Wu Q, (2005) Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. Genetics 169: 2179-2188.
15. Tukey RH, Strassburg CP, (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40: 581-616.
16. Mackenzie PI, Walter Bock K, Burchell B, Guillemette C, Ikushiro S, et al. (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15: 677-685.
17. Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, et al. (1992) A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 267: 3257-3261.
18. Owens IS, Basu NK, Banerjee R, (2005) UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 400: 1-22.
19. Huang H, Wu Q, (2010) Cloning and comparative analyses of the zebrafish Ugt repertoire reveal its evolutionary diversity. PLoS One 5: e9144.
20. Locuson CW, Tracy TS, (2007) Comparative modelling of the human UDP-glucuronosyltransferases: insights into structure and mechanism. Xenobiotica 37: 155-168.
21. Laakkonen L, Finel M, (2010) A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme. Mol Pharmacol 77: 931-939.
22. Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, et al. (2007) Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol 369: 498-511.
23. Patana AS, Kurkela M, Goldman A, Finel M, (2007) The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site. Mol Pharmacol 72: 604-611.
24. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, et al. (2000) Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 16: 297-306.
25. Crigler JF Jr, Najjar VA, (1952) Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10: 169-180.
26. Innocenti F, Ratain MJ, (2006) Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping. Pharmacogenomics 7: 1211-1221.
27. Judson R, Stephens JC, Windemuth A, (2000) The predictive power of haplotypes in clinical response. Pharmacogenomics 1: 15-26.
28. Gong QH, Cho JW, Huang T, Potter C, Gholami N, et al. (2001) Thirteen UDP glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11: 357-368.
29. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
30. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
31. Halperin E, Kimmel G, Shamir R, (2005) Tag SNP selection in genotype data for maximizing SNP prediction accuracy. Bioinformatics 21 (Suppl 1): i195-203.
32. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
33. Finel M, Li X, Gardner-Stephen D, Bratton S, Mackenzie PI, et al. (2005) Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. J Pharmacol Exp Ther 315: 1143-1149.
34. Yamanaka H, Nakajima M, Katoh M, Hara Y, Tachibana O, et al. (2004) A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 14: 329-332.
35. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333: 1171-1175.
36. Beutler E, Gelbart T, Demina A, (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95: 8170-8174.
37. Saeki M, Saito Y, Jinno H, Sai K, Ozawa S, et al. (2006) Haplotype structures of the UGT1A gene complex in a Japanese population. Pharmacogenomics J 6: 63-75.
38. Thomas SS, Li SS, Lampe JW, Potter JD, Bigler J, (2006) Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus. Hum Mutat 27: 717.
39. Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, et al. (2005) UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res 11: 1226-1236.
40. Fujita K, Ando Y, Nagashima F, Yamamoto W, Eodo H, et al. (2007) Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer. Cancer Chemother Pharmacol 60: 515-522.
41. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, et al. (2009) Finding the missing heritability of complex diseases. Nature 461: 747-753.
42. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE, (2000) Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10: 629-644.
43. Nagar S, Zalatoris JJ, Blanchard RL, (2004) Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14: 487-499.
44. Aono S, Yamada Y, Keino H, Hanada N, Nakagawa T, et al. (1993) Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 197: 1239-1244.
45. Maitland ML, Grimsley C, Kuttab-Boulos H, Witonsky D, Kasza KE, et al. (2006) Comparative genomics analysis of human sequence variation in the UGT1A gene cluster. Pharmacogenomics J 6: 52-62.
46. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
47. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, et al. (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269: 17960-17964.
48. Huang CS, Luo GA, Huang ML, Yu SC, Yang SS, (2000) Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 10: 539-544.
49. Zhou YY, Lee LY, Ng SY, Hia CP, Low KT, et al. (2009) UGT1A1 haplotype mutation among Asians in Singapore. Neonatology 96: 150-155.
50. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, et al. (1998) Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 46: 21-26.
51. Chu JY, Huang W, Kuang SQ, Wang JM, Xu JJ, et al. (1998) Genetic relationship of populations in China. Proc Natl Acad Sci USA 95: 11763-11768.
52. Yea SS, Lee SS, Kim WY, Liu KH, Kim H, et al. (2008) Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. Ther Drug Monit 30: 23-34.
53. Zhang K, Qin ZS, Liu JS, Chen T, Waterman MS, et al. (2004) Haplotype block partitioning and tag SNP selection using genotype data and their applications to association studies. Genome Res 14: 908-916.